Retraction: Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy

Affiliations

• ¹ Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ² Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ³ Threshold Pharmaceuticals, South San Francisco, CA, USA.
• ⁴ Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.